Skip to main content

Table 2 Patient characteristics of patients after propensity score matching

From: Early administration of glucocorticoid for thyroid storm: analysis of a national administrative database

  Glucocorticoid group Control group ASMD
Number of participants, n 203 203  
Age(years), median [25th–75th percentiles] 52 [41, 64] 50 [35, 66] 0.08
Sex, female, n (%) 131 (64.5) 127 (62.6) 0.04
Charlson comorbidity index, median
[25th–75th percentiles]
1 [0, 1] 1 [0, 1] < 0.01
Vasoactive-Inotropic Score (VIS), median [25th–75th percentiles] 0 [0, 0] 0 [0, 0] 0.08
Consciousness, alert, n (%) 57 (50.0) 56 (50.0) 0.03
Defibrillation, n (%) 6 (3.0) 6 (3.0) < 0.01
Mechanical ventilation use, n (%) 57 (28.1) 52 (25.6) 0.06
Renal replacement therapy, n (%) 6 (3.0) 4 (2.0) 0.06
Extra-corporeal membrane oxygenation, n (%) 4 (2.0) 3 (1.5) 0.05
Intra-aortic balloon pump, n (%) 4 (2.0) 4 (2.0) < 0.01
Acetaminophen use, n (%) 58 (28.5) 50 (24.6) 0.04
Beta-blockers use, n (%) 108 (53.2) 107 (52.7) < 0.01
Methimazole use, n (%) 111 (54.7) 112 (55.2) < 0.01
Potassium Iodide use, n (%) 83 (40.9) 83 (40.9) 0.01
Annual number of patients with thyroid storm per hospital, median [25th–75th percentiles] 7 [4, 10] 7 [3, 10] 0.06
Admission number of ICU each day per hospital, median [25th–75th percentiles] 5.4 [3.3, 7.8] 5.0 [2.9, 7.8] 0.01
Academic hospital, n (%) 46 (22.7) 45 (22.2) 0.01
  1. Abbreviation: ASMD absolute standard mean difference, ICU intensive care unit